tiprankstipranks
Trending News
More News >
Cyient DLM Limited (IN:CYIENTDLM)
:CYIENTDLM
India Market
Advertisement

Cyient DLM Limited (CYIENTDLM) AI Stock Analysis

Compare
1 Followers

Top Page

IN:CYIENTDLM

Cyient DLM Limited

(CYIENTDLM)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
₹485.00
▲(7.51% Upside)
Cyient DLM Limited's overall stock score is driven by strong financial performance, particularly in revenue growth and profitability. However, operational efficiency and cash flow management need improvement. The technical analysis indicates neutral momentum, and the valuation suggests the stock is overvalued, which impacts its attractiveness.

Cyient DLM Limited (CYIENTDLM) vs. iShares MSCI India ETF (INDA)

Cyient DLM Limited Business Overview & Revenue Model

Company DescriptionCyient DLM Limited provides electronic manufacturing solutions in India and internationally. The company offers integrated manufacturing, electronics manufacturing, mechanical manufacturing, additive manufacturing, and value-added services. It also engages in the machining of components for aerospace, automotive, and defense industries. The company serves aerospace and defense, automotive, communications, energy, geospatial, industrial and heavy equipment, healthcare and life sciences, mining, oil and gas, power generation, rail transportation, semiconductor, and utilities industries. The company was founded in 1991 and is based in Mysuru, India. Cyient DLM Limited is a subsidiary of Cyient Limited.
How the Company Makes MoneyCyient DLM generates revenue primarily through its engineering and technology services, which involve project-based contracts, long-term partnerships, and service agreements with clients across different industries. Key revenue streams include consulting services, custom engineering solutions, and outsourcing of manufacturing processes. The company may also engage in strategic partnerships with technology providers and industry leaders to enhance its service offerings and expand its market reach. These collaborations often lead to joint ventures or co-development initiatives that contribute to additional revenue opportunities.

Cyient DLM Limited Financial Statement Overview

Summary
Cyient DLM Limited shows strong revenue growth and profitability improvements, with a solid equity base. However, challenges in operational efficiency, high liabilities, and cash flow management need strategic focus.
Income Statement
82
Very Positive
Cyient DLM Limited has demonstrated robust revenue growth over the past few years, with the most recent annual revenue showing a significant increase of 27.5% compared to the previous year. The gross profit margin has improved to 27.1% from the prior year's 22.3%, indicating enhanced efficiency in managing production costs. Net profit margin also improved slightly to 4.5%. However, the EBIT margin has decreased to 6.8% from the previous year, suggesting some challenges in operational efficiency. Overall, the income statement reflects strong revenue growth, improved profitability, but slight operational efficiency concerns.
Balance Sheet
75
Positive
The balance sheet of Cyient DLM Limited shows a healthy equity position with a significant increase in stockholders' equity to 56.1% of total assets. The debt-to-equity ratio has improved to 0.32 from 0.21, suggesting better leverage management. However, total liabilities remain high in relation to total assets, posing potential risk. The return on equity has decreased to 7.2% from the previous year, indicating lower efficiency in generating returns from the equity. While the company maintains a stable equity base, high liabilities and declining ROE require attention.
Cash Flow
65
Positive
Cyient DLM Limited's cash flow statement indicates challenges with generating free cash flow, as seen by the negative free cash flow of -2.28 billion. The operating cash flow to net income ratio is negative, reflecting inefficiencies in cash generation from operations. Despite these challenges, the company has managed its capital expenditures effectively. Overall, the cash flow situation highlights significant areas for improvement in operational cash management.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.40B15.20B11.92B8.32B7.21B6.28B
Gross Profit4.58B1.71B2.66B1.87B1.77B1.33B
EBITDA1.64B1.63B1.39B940.91M919.91M548.27M
Net Income649.43M680.76M611.96M317.27M397.95M118.14M
Balance Sheet
Total Assets0.0016.94B16.03B11.05B7.77B6.45B
Cash, Cash Equivalents and Short-Term Investments471.17M2.82B4.58B773.41M768.59M163.95M
Total Debt0.003.01B1.92B3.56B3.37B2.79B
Total Liabilities-9.49B7.44B6.94B9.07B7.00B6.07B
Stockholders Equity9.49B9.49B9.09B1.98B771.12M376.52M
Cash Flow
Free Cash Flow0.00-2.28B-1.04B445.03M401.23M75.41M
Operating Cash Flow0.00-623.94M-705.41M521.05M485.37M349.28M
Investing Cash Flow0.001.27B-4.28B-1.42B-324.14M-9.01M
Financing Cash Flow0.00-587.28M4.79B721.78M460.67M-428.16M

Cyient DLM Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price451.10
Price Trends
50DMA
447.34
Positive
100DMA
456.87
Negative
200DMA
463.35
Negative
Market Momentum
MACD
1.54
Negative
RSI
49.45
Neutral
STOCH
34.77
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CYIENTDLM, the sentiment is Negative. The current price of 451.1 is above the 20-day moving average (MA) of 447.85, above the 50-day MA of 447.34, and below the 200-day MA of 463.35, indicating a neutral trend. The MACD of 1.54 indicates Negative momentum. The RSI at 49.45 is Neutral, neither overbought nor oversold. The STOCH value of 34.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CYIENTDLM.

Cyient DLM Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
₹51.00B24.900.56%15.72%13.40%
70
Outperform
₹26.47B15.811.24%4.85%1.23%
67
Neutral
₹150.18B69.880.19%-3.83%103.32%
65
Neutral
₹36.73B44.979.86%21.38%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
₹74.69B92.6046.95%326.05%
52
Neutral
₹37.16B530.870.24%8.64%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CYIENTDLM
Cyient DLM Limited
451.10
-154.60
-25.52%
IN:AVALON
Avalon Technologies Limited
1,119.50
545.40
95.00%
IN:CENTUM
Centum Electronics Limited
2,526.45
844.90
50.25%
IN:DATAMATICS
Datamatics Global Services Limited
902.15
345.13
61.96%
IN:NUCLEUS
Nucleus Software Exports Limited
1,004.25
-150.66
-13.05%
IN:SYRMA
Syrma SGS Technology Limited
773.35
342.50
79.49%

Cyient DLM Limited Corporate Events

Cyient DLM Limited Releases Q2 FY26 Earnings Call Transcript
Oct 21, 2025

Cyient DLM Limited has released the transcript of its earnings conference call for the second quarter of the fiscal year 2026. The call, which took place on October 14, 2025, discussed the company’s financial results and performance. This information is now available on the company’s website, providing stakeholders with insights into the company’s operational strategies and financial health.

Cyient DLM Releases Q2 Earnings Call Recording
Oct 14, 2025

Cyient DLM Limited announced the availability of a recording for their recent earnings call, which discussed the financial results for the second quarter. This announcement ensures transparency and accessibility for stakeholders, potentially impacting investor confidence and market perception positively.

Cyient DLM Limited Schedules Investor Meetings for September 2025
Sep 19, 2025

Cyient DLM Limited announced its participation in upcoming investor meetings scheduled for September 24 and 25, 2025. The meetings will involve key company executives, including the MD & CEO, CFO, and AVP, engaging with investors both physically and virtually. The company emphasized that no unpublished price-sensitive information will be disclosed during these sessions, maintaining compliance with regulatory standards.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 25, 2025